
Ketogenic diets may affect more than how the body burns energy.
Ketogenic diets have gained attention for their effects on metabolism, weight loss, and potentially even cancer treatment. But their influence on inflammation has puzzled scientists, with some studies suggesting they reduce inflammation and others finding the opposite.
Now, new research from the University of Cincinnati Cancer Center offers a possible explanation, suggesting that the key may not simply be how much fat a ketogenic diet contains, but which types of fat are consumed.
Different fats, different immune responses
A ketogenic diet is high in fat and low in carbohydrates, pushing the body into ketosis, a state in which it burns fat and ketones for fuel instead of glucose. To investigate the conflicting findings, researchers fed mice ketogenic diets containing different fatty acids and tested individual fatty acids in tissue cultures.
“We followed the research data while studying a different aspect of ketogenic diets and found something unexpected,” said David Gius, MD, PhD, director of the University of Cincinnati Cancer Center, professor in the Department of Radiation Oncology at UC’s College of Medicine, and UC Health physician. “Our previous studies have found that all ketogenic diets are not the same, with different fats causing different metabolic changes.”
“We found that long-chain saturated fatty acids seem to favor an inflammatory immune response, whereas unsaturated and medium-chain fatty acids tend to favor anti-inflammatory characteristics.”
The researchers traced the increased inflammation to stress signals from mitochondria, the structures that help cells produce energy, and the activation of immune cells. Their findings, published November 13 in Science Advances, build on earlier studies in Science Advances (2024) and Cell Reports (2025), suggesting that dietary fat sources and other factors may influence the effects of a ketogenic diet.
Could ketogenic diets influence cancer treatment?
Although the experiments involved mice and tissue cultures rather than humans, the findings could have implications for cancer treatment. Gius said ketogenic diets may change the environment surrounding tumors in ways that improve responses to immunotherapy, which helps the immune system fight cancer.
A clinical trial is underway at UT Health San Antonio, where Gius began the research, and is expected to open soon at the University of Cincinnati Cancer Center to investigate further.
Reference: “Ketogenic diets induce proinflammatory macrophage accumulation through long-chain saturated fatty acids driving cGAS-STING signaling” by Sung-Jen Wei, Joseph Schell, Maiko Sezaki, Agne Baseviciene, Wei Qian, Wan Hsi Chen, Rolando TrevinoJr, Prethish Sreenivas, Estrella Sandra Chocron, Haiyan Jiang, Felix F. Dong, Jenny Chang, Alia Nazarullah, Gang Huang, Erin Munkácsy, Nobuo Horikoshi and David Gius, 13 November 2026, Science Advances.
DOI: 10.1126/sciadv.aeg5542
This work was funded by the National Cancer Institute (NCI) grants R01CA257148 (D.G.) and R01CA214025 (D.G.) and supplements to R01CA257148 (R.T.) and R01CA152601 (E.S.C.). This work was also supported by the Cancer Prevention and Research Institute of Texas (CPRIT) grant RR20012 (D.G.) and the National Institute on Aging (NIA) Training Program for Research Scientists in the Biology of Aging T32AG021890-20 (J.S.).
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.